0001123292-20-000973.txt : 20200707 0001123292-20-000973.hdr.sgml : 20200707 20200707174114 ACCESSION NUMBER: 0001123292-20-000973 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200707 FILED AS OF DATE: 20200707 DATE AS OF CHANGE: 20200707 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KDev Investments AB CENTRAL INDEX KEY: 0001789888 STATE OF INCORPORATION: V7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39069 FILM NUMBER: 201016780 BUSINESS ADDRESS: STREET 1: TOMTEBODAVAGEN 23A CITY: SOLNA STATE: V7 ZIP: SE 171 65 BUSINESS PHONE: 08-524 860 70 MAIL ADDRESS: STREET 1: TOMTEBODAVAGEN 23A CITY: SOLNA STATE: V7 ZIP: SE 171 65 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Karolinska Development AB CENTRAL INDEX KEY: 0001789932 STATE OF INCORPORATION: V7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39069 FILM NUMBER: 201016781 BUSINESS ADDRESS: STREET 1: TOMTEBODAVAGEN 23A CITY: SOLNA STATE: V7 ZIP: SE 171 65 BUSINESS PHONE: 08-524 860 70 MAIL ADDRESS: STREET 1: TOMTEBODAVAGEN 23A CITY: SOLNA STATE: V7 ZIP: SE 171 65 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KCIF Co-Investment Fund KB CENTRAL INDEX KEY: 0001789966 STATE OF INCORPORATION: V7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39069 FILM NUMBER: 201016782 BUSINESS ADDRESS: STREET 1: TOMTEBODAVAGEN 23A CITY: SOLNA STATE: V7 ZIP: SE 171 65 BUSINESS PHONE: 08-524 860 70 MAIL ADDRESS: STREET 1: TOMTEBODAVAGEN 23A CITY: SOLNA STATE: V7 ZIP: SE 171 65 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aprea Therapeutics, Inc. CENTRAL INDEX KEY: 0001781983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 535 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6095104718 MAIL ADDRESS: STREET 1: 535 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2020-07-07 1 0001781983 Aprea Therapeutics, Inc. APRE 0001789888 KDev Investments AB TOMTEBODAVAGEN 23A SOLNA V7 SE-17165 SWEDEN 0 0 1 0 0001789932 Karolinska Development AB TOMTEBODAVAGEN 23A SOLNA V7 SE-17165 SWEDEN 0 0 1 0 0001789966 KCIF Co-Investment Fund KB TOMTEBODAVAGEN 23A SOLNA V7 SE-17165 SWEDEN 0 0 1 0 Common Stock 2020-07-07 4 S 0 241703 34.55 D 1992586 I See Footnote The amount of securities of Aprea Therapeutics, Inc. (the "Issuer") reported as beneficially owned includes shares held of record by: KDev Investments AB, Karolinska Development AB and KCIF Co-Investment Fund KB (collectively, the "Reporting Persons"). Karolinska Development AB ("Karolinska") is the majority owner and co-manager of KDev Investments AB and a limited partner of KCIF Co-Investment Fund KB. Karolinska and each of the other Reporting Persons disclaim beneficial ownership of any shares of the Issuer's Common Stock owned of record by any of the other Reporting Persons except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that any such entity is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. The address of each of (i) KDev Investments AB, (ii) Karolinska Development AB, and (iii) KCIF Co-Investment Fund KB is Tomtebodavagen 23A, SE 171 65 Solna, Sweden. KDev Investments AB By: /s/ Viktor Drvota 2020-07-07 Karolinska Development AB By: /s/ Viktor Drvota 2020-07-07 KCIF Co-Investment Fund KB By: /s/ Fredrik Jarrsten, attorney-in-fact 2020-07-07